The strong life science actors in Norway joined forces during Nordic Life Science Days 2018.
What is driving the next wave of innovation in cancer immunotherapy?
Ultimovacs acquires the immunotherapy technology business of the Swedish company Immuneed AB.
PCI Biotech is initiating a scientific collaboration with Bavarian Nordic to boost their cancer treatment technology. Oslo Cancer Cluster member PCI Biotech has announced that it is initiating a preclinical research collaboration with Bavarian Nordic, a clinical stage biopharmaceutical corporation focused on developing state-of-the-art cancer immunotherapies and vaccines for infectious diseases. The two collaborators will […]
CEO of Ultimovacs Øyvind Kongstun Arnesen is the new chairman of Oslo Cancer Cluster. Get to know the guy!
Are you and your cluster company in need of early stage funding?